Quetiapine Fumarate111974-72-2,Antipsychotic/Antimanic API

Quetiapine Fumarate is a clinically proven atypical antipsychotic indicated for the management of complex neuropsychiatric conditions. It works by modulating a specific spectrum of neurotransmitter receptors in the brain, functioning as an antagonist at serotonin 5HT2 and dopamine D2 receptors, while also interacting with histamine and adrenergic pathways. This balanced mechanism of action makes it highly effective in stabilizing mood fluctuations, reducing acute psychotic symptoms, and alleviating severe depressive episodes associated with Bipolar Disorder and Schizophrenia. Available in both immediate-release (IR) and extended-release (XR) formulations, Quetiapine Fumarate provides clinicians with the dosing flexibility needed to achieve optimal patient outcomes and restore cognitive balance.